Scientific Session
Systemic lupus erythematosus (SLE)
David Karp, MD, PhD
UT Southwestern Medical Center
Dallas, TX, United States
Disclosure(s): Ampel Biosciences: Consultant (Ongoing); Biogen: Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Celgene: Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); Provention Bio: Advisor or Review Panel Member (Ongoing); Rilite: Grant/Research Support (Terminated, March 3, 2023); UCB: Grant/Research Support (Ongoing)